ICU MEDICAL INC/DE Quarterly Amortization of Intangible Assets in USD from Q1 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Icu Medical Inc/De quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2016 to Q2 2024.
  • Icu Medical Inc/De Amortization of Intangible Assets for the quarter ending June 30, 2024 was $33.1M, unchanged year-over-year.
  • Icu Medical Inc/De Amortization of Intangible Assets for the twelve months ending June 30, 2024 was $133M, a 1.07% increase year-over-year.
  • Icu Medical Inc/De annual Amortization of Intangible Assets for 2023 was $132M, a 5.24% decline from 2022.
  • Icu Medical Inc/De annual Amortization of Intangible Assets for 2022 was $139M, a 486% increase from 2021.
  • Icu Medical Inc/De annual Amortization of Intangible Assets for 2021 was $23.8M, a 2.59% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $133M $33.1M $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $133M $33.1M +$800K +2.48% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $132M $33.3M +$2.8M +9.18% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $129M $33.4M -$2.2M -6.18% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $132M $33.1M -$8.5M -20.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $140M $32.3M +$600K +1.89% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $139M $30.5M +$24.1M +377% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $115M $35.6M +$29.8M +514% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $85.5M $41.6M +$35.8M +617% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $49.7M $31.7M +$25.9M +447% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $23.8M $6.4M +$600K +10.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $23.2M $5.8M $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $23.2M $5.8M $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $23.2M $5.8M $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $23.2M $5.8M +$500K +9.43% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $22.7M $5.8M +$1.4M +31.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $21.3M $5.8M +$1.8M +45% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $19.5M $5.8M +$1.8M +45% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $17.7M $5.3M +$900K +20.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $16.8M $4.4M +$300K +7.32% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $16.5M $4M $0 0% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $16.5M $4M -$100K -2.44% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $16.6M $4.4M +$300K +7.32% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $16.3M $4.1M +$500K +13.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $15.8M $4M +$100K +2.56% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $15.7M $4.1M +$700K +20.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $15M $4.1M +$3.4M +486% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $11.6M $3.6M +$2.9M +414% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $8.7M $3.9M +$3.2M +457% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $5.5M $3.4M +$2.7M +386% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $2.8M $700K Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 $700K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $700K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $700K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.